Exit Readiness Checklist · Medical Billing Company

Is Your Medical Billing Company Ready to Sell?

Follow this step-by-step exit readiness checklist to maximize your valuation multiple, reduce buyer risk concerns, and close a deal in 12–18 months — without surprises derailing your transaction.

Medical billing companies typically sell for 3.5x–6x EBITDA, but most owner-operators leave significant value on the table by going to market unprepared. Buyers — whether private equity-backed RCM roll-ups, national revenue cycle management platforms, or SBA-financed individual operators — will scrutinize your client concentration, compliance history, collection rate performance, and technology infrastructure. A single compliance gap, undocumented client contract, or over-reliance on you as the owner can compress your multiple or kill a deal entirely. This checklist gives you a 12–18 month roadmap to systematically address every issue buyers will raise, organize your documentation, and position your business at the top of its valuation range. Work through each phase sequentially to build a clean, buyer-ready business that commands premium pricing.

Get Your Free Medical Billing Company Exit Score

5 Things to Do Immediately

  • 1Pull your net collection rate reports from the past 24 months by client and specialty, and identify any accounts falling below 93% — address the root cause before a buyer finds it first
  • 2Contact any client operating without a signed service agreement and schedule a call to execute a formal contract, framing it as a routine administrative update rather than a sales-related change
  • 3Engage a HIPAA compliance consultant to audit your Business Associate Agreements and identify any clients or vendors missing signed BAAs — this can be completed in 2–4 weeks and removes a major deal-stopper
  • 4Begin documenting your denial management workflow in writing, starting with the steps your team takes within 24 hours of receiving a claim denial — this is the most common SOP gap buyers find in medical billing companies
  • 5Schedule a call with a CPA experienced in healthcare services businesses to review your last two years of financial statements and identify personal expenses or non-recurring items that can be legitimately added back to increase your adjusted EBITDA

Phase 1: Financial Housekeeping and Revenue Documentation

Months 1–3

Commission a CPA-prepared quality of earnings analysis or clean up 3 years of financial statements

highCan expand your multiple by 0.5x–1x by reducing buyer-perceived financial risk and enabling SBA financing eligibility

Buyers and their lenders — especially SBA 7(a) lenders — require at minimum three years of accrual-basis financial statements. If your books are cash-basis, owner-managed, or commingled with personal expenses, engage a CPA experienced in healthcare services businesses immediately. Separate all owner perks, normalize add-backs, and document them clearly.

Break out revenue by client, specialty, and billing arrangement (percentage-of-collections vs. flat fee)

highDocumented revenue diversification directly supports the higher end of the 3.5x–6x valuation range

Buyers need to understand the composition and quality of your revenue. Create a client-level revenue schedule showing monthly billing volume, the fee structure in place, specialty served, and client tenure. This demonstrates revenue diversity and makes it easy to spot — and proactively address — concentration issues before they surface in due diligence.

Calculate and document your trailing net collection rate by specialty and by client

highStrong collection rate performance can add 0.5x to your EBITDA multiple compared to peers with declining metrics

Your net collection rate is the single most important operational metric in a medical billing business. Buyers want to see 95%+ net collection rates sustained over 24–36 months. Pull this data from your practice management system and organize it by client and specialty. If rates are below benchmark, identify root causes and begin remediation now.

Identify and document all owner add-backs and discretionary expenses run through the business

highEvery $50,000 in defensible add-backs translates to $175,000–$300,000 in additional transaction value at prevailing multiples

Normalize EBITDA by identifying personal vehicle expenses, owner health insurance, above-market owner compensation, and any one-time costs that will not recur post-acquisition. Each legitimately documented add-back increases your adjusted EBITDA and therefore your transaction value. Have your CPA or M&A advisor review add-backs for defensibility under SBA and buyer scrutiny.

Compile denial rate tracking and aging accounts receivable reports for the past 24 months

mediumClean denial metrics reduce buyer risk adjustments that can lower offered multiples by 0.25x–0.5x

Buyers will examine denial trends as a leading indicator of operational health and payer relationship quality. Prepare monthly denial rate reports segmented by payer and specialty, and document your denial management workflow and first-pass resolution rate. Clean AR aging with minimal balances over 120 days signals operational discipline.

Phase 2: Client Contracts and Retention Documentation

Months 2–5

Locate, organize, and review all client service agreements

highDocumented, assignable long-term contracts directly support revenue quality and can increase your valuation multiple by 0.5x or more

Every client relationship must be backed by a signed, current service agreement. Pull every contract and verify it includes the fee structure, contract term, renewal provisions, termination notice requirements, and ownership transfer or assignment clauses. Contracts without assignment clauses can create serious deal complications when a buyer acquires the business.

Identify clients without executed contracts and get agreements signed immediately

highFormalizing informal relationships converts perceived revenue risk into contracted recurring revenue, protecting your valuation

It is common in smaller billing companies for long-tenured clients to operate on handshake arrangements or expired agreements. Buyers will not pay full price for undocumented revenue. Prioritize getting signed agreements with any client representing more than 2% of revenue. Frame this to clients as an administrative update, not a sales process.

Prepare a client retention summary showing tenure, volume, and churn history

highClient retention rates above 90% with average tenure exceeding five years can push valuations toward the 5x–6x range

Create a one-page client retention summary showing how long each client has been with your business, their annual billing volume processed, and collection rate performance. Include a separate schedule of any clients lost in the past five years, the reason for departure, and the revenue impact. Demonstrating low churn rates is one of the most powerful value drivers for RCM businesses.

Identify and resolve client concentration risk before going to market

highReducing top-client concentration below 20% of total revenue can add 0.5x–1x to your EBITDA multiple

If any single client represents more than 25–30% of your revenue, buyers will heavily discount your valuation or require a larger earnout to protect against client departure risk. Begin proactively adding new clients from adjacent specialties or geographies to dilute concentration. Even moving a dominant client from 35% to 25% of revenue meaningfully reduces deal risk.

Document specialty-specific billing expertise and client referral sources

mediumDemonstrable specialty expertise with verified switching costs supports premium multiples in the 5x–6x range

Compile evidence of your specialty knowledge — CPT code expertise in anesthesia, behavioral health, or radiology, for example — and document how clients typically find your business. Specialty expertise creates switching costs that buyers recognize as a competitive moat. Referral source documentation also helps buyers understand organic growth potential.

Phase 3: HIPAA Compliance and Regulatory Clean-Up

Months 3–6

Conduct a HIPAA security risk assessment and remediate identified gaps

highA documented, clean compliance posture eliminates the risk of buyers requesting escrow holdbacks of 10–20% of deal value for compliance indemnification

Every buyer and their counsel will perform a HIPAA compliance review during due diligence. Engage a qualified healthcare compliance consultant to conduct a formal HIPAA security risk assessment now. Document all findings and remediation steps taken. Buyers are far more comfortable with disclosed and remediated historical gaps than with gaps they discover themselves during due diligence.

Verify and compile signed Business Associate Agreements with all clients and vendors

highComplete BAA documentation removes a common contingency that buyers use to reduce purchase price or extend escrow periods

Every client sending you protected health information must have a current, signed Business Associate Agreement. The same applies to your software vendors, cloud storage providers, IT support firms, and any subcontractors. Create a BAA tracker showing counterparty name, execution date, and renewal status. Missing BAAs are a red flag that can slow or derail a deal.

Document any prior HIPAA breaches, OIG inquiries, or payer audits with resolution records

highProactive disclosure with documented resolution protects deal certainty and prevents post-close indemnification claims

Undisclosed compliance events discovered during due diligence are deal killers. Disclose any prior breach notifications, payer recoupment demands, or OIG correspondence proactively — along with complete documentation of how each was resolved. Buyers can underwrite disclosed and closed issues; they cannot underwrite unknown liabilities.

Verify coder and biller certifications (CPC, CCS) and document training records

mediumA fully certified coding team can justify a higher personnel quality adjustment in buyer valuation models

Compile certification documentation for all coding and billing staff, including CPC, CCS, or CPMA credentials. Certified coders reduce compliance risk and signal operational quality to buyers. If key coders are uncertified, enroll them in AAPC or AHIMA certification programs now — certifications earned before close meaningfully strengthen your staffing story.

Review payer enrollment files and ensure all providers are properly enrolled with current credentialing

mediumClean payer enrollment records reduce buyer concerns about post-close revenue disruption, protecting earnout performance

Verify that every provider you bill for has complete, current payer enrollment files maintained in your system. Lapsed credentialing or missing enrollment documentation creates payer audit risk and billing interruptions that buyers will flag. Clean enrollment files also demonstrate operational discipline and reduce transition risk for incoming ownership.

Phase 4: Operations Documentation and Process Standardization

Months 4–9

Document standard operating procedures for all core billing and denial management workflows

highDocumented operational systems are a prerequisite for accessing the 5x–6x multiple range; businesses without SOPs are typically valued at the lower 3.5x–4.5x range

Create written SOPs for every core function: charge capture, claims submission, denial management, patient collections, coding review, and month-end reporting. These documents demonstrate that your business runs on systems rather than institutional knowledge held by you or one or two key employees. Buyers — especially PE-backed acquirers — will not pay a premium for a business that cannot operate without its founder.

Build an organizational chart and identify your second-tier management team

highA capable second-tier manager who commits to staying post-acquisition can directly increase deal value by reducing the transition earnout requirement buyers impose for owner-dependent businesses

Document your organizational structure including reporting relationships, role responsibilities, and tenure for each employee. Identify one or two employees capable of managing day-to-day operations and client relationships without direct owner involvement. If no such person exists, begin developing that capability immediately by delegating key responsibilities and increasing compensation to retain them through the transition.

Reduce owner involvement in direct client management and transition relationships to account managers

highSuccessfully transitioning client relationships away from the owner can reduce earnout requirements from 20–25% of deal value to 10–15% or eliminate them entirely

The most common value killer in medical billing company sales is the owner being the sole point of contact for major clients. Begin systematically introducing account managers or team leads to client contacts. Document this transition. Buyers need confidence that clients will stay with the business under new ownership — and that confidence comes from evidence that relationships already extend beyond you.

Inventory all software licenses, EHR integrations, and technology subscriptions

mediumA clean technology inventory with transferable agreements eliminates a common source of post-LOI renegotiation

Create a complete technology inventory listing every software platform in use, associated license agreements, monthly or annual costs, contract terms, and renewal dates. Include your practice management system, clearinghouse agreements, EHR integration credentials, cybersecurity tools, and cloud storage. Buyers need to understand what they are acquiring and whether technology contracts are transferable.

Assess your technology infrastructure for obsolescence and begin modernization where needed

mediumModern, supported technology infrastructure removes discounts of 0.5x or more that buyers apply to businesses facing near-term technology replacement costs

If your billing platform is legacy software with no current vendor support or lacks modern EHR API integrations, buyers will discount your valuation or factor in a technology upgrade cost. Evaluate your current stack against modern alternatives such as AdvancedMD, Kareo, or Athenahealth-integrated workflows. Even beginning a migration plan — not necessarily completing it — demonstrates strategic awareness buyers value.

Phase 5: Market Preparation and Advisor Engagement

Months 9–18

Engage a healthcare-focused M&A advisor or business broker with RCM transaction experience

highExperienced healthcare M&A advisors routinely achieve sale prices 15–25% higher than unrepresented sellers through competitive buyer processes and deal structure negotiation

Healthcare services M&A is a specialized field. A generalist business broker may not understand how to position your specialty billing expertise, normalize your financials for percentage-of-collections revenue models, or navigate the compliance disclosures buyers will require. Interview at least three advisors with verifiable RCM or healthcare services transaction experience before selecting your representative.

Work with your advisor to prepare a Confidential Information Memorandum

highA professionally prepared CIM reduces time-on-market and increases the probability of receiving multiple competing offers, which is the single most effective way to maximize sale price

The CIM is the primary marketing document buyers will use to evaluate your business. It should cover your business model and specialty mix, financial performance with normalized EBITDA, client retention metrics, compliance posture, technology infrastructure, and growth opportunities. A professional CIM signals organizational readiness and attracts more serious, better-capitalized buyers.

Prepare a client communication and transition plan for post-close notification

mediumA documented client transition plan can reduce or eliminate earnout provisions tied to post-close client retention, improving your certainty of receiving full deal value

Buyers will want to see a thoughtful plan for how clients will be notified of ownership change and how continuity of service will be managed during the first 90–180 days post-close. Document your planned communication sequence, who will lead client conversations, and what service guarantees you will offer during transition. This reduces buyer perception of client attrition risk.

Consult with a tax advisor to structure the sale for optimal after-tax proceeds

highProper tax structuring can increase your net after-tax proceeds by 5–15% relative to an unplanned transaction, without changing the headline purchase price

Medical billing company sales can be structured as asset sales or stock sales, each with materially different tax implications for you as the seller. Engage a CPA with M&A transaction experience to model your after-tax proceeds under multiple deal structures before you receive offers. Understanding your walkaway number on an after-tax basis is essential to evaluating deal terms rationally.

Establish a clean data room and upload all due diligence documents before receiving offers

mediumA complete data room at LOI stage routinely shortens due diligence by 30–60 days, reducing deal risk and maintaining negotiating leverage throughout the process

Organize all financial statements, client contracts, compliance documentation, SOPs, technology licenses, employee records, and BAAs into a structured virtual data room. Having this ready before you accept a letter of intent dramatically reduces due diligence timeline and signals organizational credibility to buyers. Extended due diligence periods increase deal fall-through risk and give buyers leverage to renegotiate terms.

See What Your Medical Billing Company Business Is Worth

Free exit score, valuation range, and personalized action plan — 5 minutes.

Get Free Score

Frequently Asked Questions

What valuation multiple should I expect when selling my medical billing company?

Medical billing companies in the $1M–$5M revenue range typically sell for 3.5x–6x EBITDA. Where your business lands in that range depends on several factors: client concentration and contract quality, your net collection rate performance, HIPAA compliance posture, technology infrastructure, and the degree to which the business can operate without you. A business with diversified clients on long-term contracts, documented SOPs, certified staff, and a capable second-tier manager commands 5x–6x. A business with undocumented clients, owner-dependent operations, and compliance gaps will struggle to exceed 3.5x–4x.

How long does it take to sell a medical billing company?

Plan for a 12–18 month total timeline from the start of exit preparation to receiving your wire transfer at closing. The preparation phase — cleaning up financials, organizing contracts, auditing compliance, and documenting operations — typically takes 9–12 months. Once you engage an M&A advisor and go to market, a competitive buyer process typically takes 3–6 additional months through LOI, due diligence, and closing. Rushing to market before you are ready almost always results in a lower price or a failed transaction.

Will my clients leave if they find out I am selling the business?

Client attrition is the most common buyer concern in medical billing company acquisitions, and managing this risk is central to maximizing your deal value. Clients rarely leave purely because of an ownership change — they leave when they experience service disruption or when they do not trust the new ownership. Mitigating this means transitioning client relationships from you to account managers before you go to market, documenting your transition plan, and selecting a buyer who will keep your existing team in place. Most buyers will also require a 6–18 month transition period where you remain available to clients, and many deals include earnout provisions tied to client retention post-close.

What compliance issues are most likely to come up during due diligence?

The four most common HIPAA and compliance issues that surface in medical billing due diligence are: missing or expired Business Associate Agreements with clients or vendors, absence of a documented HIPAA security risk assessment, undisclosed prior breaches or payer recoupment demands, and reliance on billing practices that were informal or undocumented. Any of these can result in buyers requesting escrow holdbacks of 10–20% of the purchase price, indemnification provisions, or price reductions. Proactively auditing your compliance posture and remediating gaps before going to market is the most cost-effective way to protect your valuation.

Do I need an M&A advisor or can I sell my medical billing company on my own?

You can attempt to sell without an advisor, but it almost always costs you more than the advisor's fee. Healthcare services M&A involves specialized compliance disclosures, revenue normalization for percentage-of-collections business models, and buyer negotiation around earnouts and escrow provisions that require experienced representation. Sellers represented by advisors with RCM transaction experience consistently achieve higher multiples, better deal terms, and lower deal-fall-through rates than unrepresented sellers. Interview advisors who can provide verifiable healthcare services transaction references and select one who understands how buyers value billing software integrations, collection rate benchmarks, and coding staff certifications.

How does SBA financing affect my sale process?

Medical billing companies are SBA 7(a) eligible businesses, meaning individual buyers can finance 80–90% of the purchase price through an SBA loan at competitive rates. This is a significant advantage because it dramatically expands your buyer pool beyond PE firms and strategic acquirers to include experienced healthcare administrators who may be excellent operators but lack large pools of capital. However, SBA financing requires clean, CPA-prepared financials, a formal business valuation, and a thorough underwriting process. To remain SBA-eligible, your books must be organized, your EBITDA clearly documented, and your business structure straightforward. SBA transactions also typically require a seller note of 5–10% of the purchase price on standby, which is worth factoring into your net proceeds expectations.

What is an earnout and how likely am I to receive it?

An earnout is a provision in your purchase agreement that ties a portion of your total sale price — typically 15–25% in medical billing transactions — to the business achieving specific performance targets after the sale closes, most commonly client retention and revenue thresholds over 12–24 months post-close. Earnouts are more common when buyers perceive transition risk, particularly from owner-dependent client relationships or client concentration. You are more likely to receive your full earnout if you remain actively involved during the transition period, your team stays intact, and clients receive consistent service under new ownership. To minimize your exposure to earnout risk, focus your exit preparation on reducing owner dependency and formalizing client relationships before going to market.

More Medical Billing Company Seller Guides

More Exit Checklists

Start Your Free Exit Assessment

Get your Medical Billing Company exit score, estimated valuation, and a step-by-step action plan — free, in 5 minutes.

Start Your Free Exit Assessment

Free forever · No broker needed · Takes 5 minutes